MGRX · ISSUER CIK 1938046
MANGOCEUTICALS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 3 MANGOCEUTICALS, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202608:00 | Aug 11, 2026from Sep 30, 2025 | MGRX | Chief Executive Officer, Director, 10% Owner · +1 joint | G · GiftLate 56d | — | −2,500,000 | 0 | -100% | — | ||
| Oct 6, 202608:00 | Aug 11, 2026from Sep 30, 2025 | MGRX | Chief Executive Officer, Director, 10% Owner · +1 joint | G · GiftLate 56d | — | +2,500,000 | 3,305,000 | +311% | — | ||
| Oct 6, 202608:00 | Jul 28, 2026 | MGRX | Chief Executive Officer, Director, 10% Owner · +1 joint | A · GrantLate 70d | — | +2,000,000 | 2,000,000 | New | — | ||
| Oct 6, 202608:00 | Jul 28, 2026 | MGRX | CFO | A · GrantLate 70d | — | +100,000 | 220,000 | +83% | — | ||
| Oct 6, 202608:00 | Jul 28, 2026 | MGRX | Director | A · GrantLate 70d | — | +100,000 | 101,667 | +5999% | — |